Giovanna Sophia Manzano (Brunetto), M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 4 | 2023 | 3079 | 0.940 |
Why?
|
Limbic Encephalitis | 1 | 2023 | 34 | 0.930 |
Why?
|
Familial Mediterranean Fever | 1 | 2023 | 61 | 0.880 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2023 | 67 | 0.870 |
Why?
|
Hashimoto Disease | 1 | 2023 | 97 | 0.860 |
Why?
|
Neuromyelitis Optica | 2 | 2022 | 252 | 0.790 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2021 | 66 | 0.770 |
Why?
|
Optic Neuritis | 2 | 2022 | 166 | 0.770 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2021 | 60 | 0.750 |
Why?
|
Demyelinating Diseases | 1 | 2023 | 354 | 0.740 |
Why?
|
Seizures, Febrile | 1 | 2021 | 111 | 0.740 |
Why?
|
Encephalitis | 1 | 2023 | 423 | 0.710 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 41 | 0.640 |
Why?
|
Clozapine | 1 | 2021 | 498 | 0.630 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2021 | 640 | 0.600 |
Why?
|
Neurotoxicity Syndromes | 1 | 2021 | 290 | 0.590 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2022 | 518 | 0.580 |
Why?
|
Interferon Type I | 1 | 2020 | 542 | 0.580 |
Why?
|
Muscular Diseases | 1 | 2020 | 556 | 0.550 |
Why?
|
Methotrexate | 1 | 2021 | 1727 | 0.490 |
Why?
|
Antipsychotic Agents | 1 | 2021 | 3057 | 0.310 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3523 | 0.260 |
Why?
|
HTLV-I Infections | 2 | 2015 | 101 | 0.250 |
Why?
|
Human T-lymphotropic virus 1 | 2 | 2015 | 140 | 0.240 |
Why?
|
Autoantibodies | 2 | 2023 | 2035 | 0.240 |
Why?
|
Aquaporin 4 | 2 | 2022 | 153 | 0.240 |
Why?
|
Roseolovirus Infections | 1 | 2014 | 45 | 0.230 |
Why?
|
Herpesvirus 6, Human | 1 | 2014 | 95 | 0.230 |
Why?
|
Schizophrenia | 1 | 2021 | 6882 | 0.220 |
Why?
|
Tremor | 1 | 2023 | 175 | 0.220 |
Why?
|
Colchicine | 1 | 2023 | 243 | 0.210 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2021 | 16 | 0.200 |
Why?
|
Antipyretics | 1 | 2021 | 23 | 0.200 |
Why?
|
Dysarthria | 1 | 2021 | 57 | 0.200 |
Why?
|
Plasmapheresis | 1 | 2021 | 211 | 0.190 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6171 | 0.180 |
Why?
|
Diplopia | 1 | 2021 | 200 | 0.180 |
Why?
|
Confusion | 1 | 2021 | 275 | 0.170 |
Why?
|
Methylprednisolone | 1 | 2020 | 387 | 0.170 |
Why?
|
Virus Activation | 1 | 2021 | 319 | 0.170 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 275 | 0.160 |
Why?
|
Alanine | 1 | 2020 | 572 | 0.160 |
Why?
|
Muscle Weakness | 1 | 2021 | 413 | 0.160 |
Why?
|
Acetaminophen | 1 | 2021 | 545 | 0.150 |
Why?
|
Optic Nerve Diseases | 1 | 2020 | 327 | 0.150 |
Why?
|
Tears | 1 | 2018 | 256 | 0.150 |
Why?
|
Steroids | 1 | 2022 | 930 | 0.150 |
Why?
|
Hematuria | 1 | 2018 | 235 | 0.150 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 652 | 0.140 |
Why?
|
Prednisone | 1 | 2020 | 1574 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2020 | 506 | 0.130 |
Why?
|
Craniopharyngioma | 1 | 2018 | 281 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.130 |
Why?
|
Exanthema | 1 | 2018 | 501 | 0.120 |
Why?
|
Humans | 17 | 2023 | 744343 | 0.110 |
Why?
|
Recurrence | 2 | 2021 | 8340 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2021 | 1580 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2022 | 63114 | 0.100 |
Why?
|
DNA, Viral | 2 | 2015 | 2225 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1130 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3176 | 0.090 |
Why?
|
Viral Load | 2 | 2015 | 3299 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1345 | 0.090 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.090 |
Why?
|
Middle Aged | 6 | 2022 | 213383 | 0.080 |
Why?
|
Stem Cells | 1 | 2022 | 3567 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.080 |
Why?
|
Monocytes | 1 | 2015 | 2596 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4931 | 0.060 |
Why?
|
Female | 7 | 2023 | 380194 | 0.060 |
Why?
|
Adult | 5 | 2023 | 214055 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 77449 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18370 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12959 | 0.060 |
Why?
|
Serum | 1 | 2014 | 214 | 0.050 |
Why?
|
Blood Donors | 1 | 2014 | 355 | 0.050 |
Why?
|
Male | 6 | 2021 | 350118 | 0.050 |
Why?
|
Saliva | 1 | 2014 | 809 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 41006 | 0.040 |
Why?
|
Optic Nerve | 1 | 2020 | 554 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1836 | 0.040 |
Why?
|
Infant | 1 | 2018 | 35136 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 518 | 0.030 |
Why?
|
Receptors, CCR | 1 | 2015 | 38 | 0.030 |
Why?
|
Receptors, CXCR | 1 | 2015 | 52 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26385 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 72290 | 0.030 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2014 | 32 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.030 |
Why?
|
Aged | 3 | 2022 | 163280 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1530 | 0.030 |
Why?
|
Phagocytosis | 1 | 2015 | 1539 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29786 | 0.020 |
Why?
|
Cell Movement | 1 | 2015 | 5217 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4386 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4479 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9239 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12804 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23338 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85781 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168757 | 0.010 |
Why?
|